These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14686734)

  • 1. Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma.
    Lesimple T; Hassel MB; Gédouin D; Seigneuret E; Carsin B; Hamlat A; Riffaud L; Simon H; Malhaire JP; Guégan Y
    J Neurooncol; 2003 Nov; 65(2):141-8. PubMed ID: 14686734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of weekly topotecan combined to concurrent external cranial irradiation in adults with glioblastoma multiforme of the brain.
    Varveris H; Petinelli E; Stratakis J; Mazonakis M
    Oncol Rep; 2008 Feb; 19(2):447-55. PubMed ID: 18202794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.
    Fisher BJ; Scott C; Macdonald DR; Coughlin C; Curran WJ
    J Clin Oncol; 2001 Feb; 19(4):1111-7. PubMed ID: 11181676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged infusional topotecan and accelerated hyperfractionated 3d-conformal radiation in patients with newly diagnosed glioblastoma--a phase I study.
    Grabenbauer GG; Anders K; Fietkau RJ; Klautke G; Feldmann HJ; Weiser S; Staab HJ; Krauseneck P; Sauer R
    J Neurooncol; 2002 Dec; 60(3):269-75. PubMed ID: 12510778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
    Kocher M; Eich HT; Semrau R; Güner SA; Müller RP
    Strahlenther Onkol; 2005 Jan; 181(1):20-5. PubMed ID: 15660189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin).
    Gross MW; Altscher R; Brandtner M; Häusser-Mischlich H; Kiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Strahlenther Onkol; 2001 Dec; 177(12):656-61. PubMed ID: 11789404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513.
    Fisher B; Won M; Macdonald D; Johnson DW; Roa W
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):980-6. PubMed ID: 12095566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.
    Anders K; Grabenbauer GG; Schuchardt U; Fahlbusch R; Fietkau R; Sauer R; Krauseneck P
    J Neurooncol; 2000 May; 48(1):63-73. PubMed ID: 11026699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
    Hochster H; Liebes L; Speyer J; Sorich J; Taubes B; Oratz R; Wernz J; Chachoua A; Blum RH; Zeleniuch-Jacquotte A
    Clin Cancer Res; 1997 Aug; 3(8):1245-52. PubMed ID: 9815806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme.
    Klautke G; Schütze M; Bombor I; Benecke R; Piek J; Fietkau R
    J Neurooncol; 2006 Apr; 77(2):199-205. PubMed ID: 16314953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 study.
    Lesimple T; Riffaud L; Frappaz D; Ben Hassel M; Gédouin D; Bay JO; Linassier C; Hamlat A; Piot G; Fabbro M; Saïkali S; Carsin B; Guégan Y
    J Neurooncol; 2009 Jun; 93(2):253-60. PubMed ID: 19139825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM; Phillips PC; Packer RJ; Heideman RL; Berg SL; Adamson PC; Allen JC; Sallan SE; Jakacki RI; Lange BJ; Reaman GH; Horowitz ME; Poplack DG; Balis FM
    Cancer; 1996 Aug; 78(3):527-31. PubMed ID: 8697400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group.
    Frangoul H; Ames MM; Mosher RB; Reid JM; Krailo MD; Seibel NL; Shaw DW; Steinherz PG; Whitlock JA; Holcenberg JS
    Clin Cancer Res; 1999 Dec; 5(12):3956-62. PubMed ID: 10632325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
    Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
    Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol.
    Lotz JP; Pautier P; Selle F; Viens P; Fabbro M; Lokiec F; Viret F; Gligorov J; Gosse B; Provent S; Ribrag V; Micléa JM; Dosquet C; Goetschel A; Cailliot C; Lefèvre G; Genève J; Lhommé C;
    Bone Marrow Transplant; 2006 Apr; 37(7):669-75. PubMed ID: 16501591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan as a 21-day continuous infusion with accelerated 3D-conformal radiation therapy for patients with glioblastoma.
    Grabenbauer GG; Buchfelder M; Schrell U; Fahlbusch R; Sauer R; Staab HJ
    Front Radiat Ther Oncol; 1999; 33():364-8. PubMed ID: 10549508
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies.
    Ghesquières H; Faivre S; Djafari L; Pautier P; Lhommé C; Lozahic S; Djazouli K; Armand JP; Raymond E
    Invest New Drugs; 2006 Sep; 24(5):413-21. PubMed ID: 16763786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.